Trade Report: Today, Opko Health Inc. (OPK) CEO Acquires $70,416.00 in Stock

Today, Opko Health Inc. (OPK) CEO Acquires $70,416.00 in Stock

Opko Health Inc. (NYSE:OPK) CEO Phillip Md Et Al Frost acquired 7,200 shares of the firm’s stock in a transaction that occurred on Tuesday, October 11th. The shares were bought at an average price of $9.78 per share, with a total value of $70,416.00. Following the acquisition, the chief executive officer now directly owns 3,068,951 shares in the company, valued at $30,014,340.78. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.

Phillip Md Et Al Frost also recently made the following trade(s): On Thursday, October 13th, Phillip Md Et Al Frost acquired 5,400 shares of Opko Health stock. The shares were bought at an average price of $9.52 per share, with a total value of $51,408.00. On Monday, October 10th, Phillip Md Et Al Frost acquired 24,800 shares of Opko Health stock. The shares were bought at an average price of $9.82 per share, with a total value of $243,536.00. On Thursday, October 6th, Phillip Md Et Al Frost acquired 4,200 shares of Opko Health stock. The shares were bought at an average price of $10.53 per share, with a total value of $44,226.00. On Tuesday, October 4th, Phillip Md Et Al Frost acquired 3,600 shares of Opko Health stock. The shares were bought at an average price of $10.57 per share, with a total value of $38,052.00. On Friday, September 30th, Phillip Md Et Al Frost purchased 1,800 shares of Opko Health stock. The stock was acquired at an average price of $10.54 per share, with a total value of $18,972.00. On Thursday, September 29th, Phillip Md Et Al Frost purchased 3,600 shares of Opko Health stock. The stock was acquired at an average price of $10.67 per share, with a total value of $38,412.00. On Wednesday, September 28th, Phillip Md Et Al Frost purchased 5,400 shares of Opko Health stock. The stock was acquired at an average price of $11.01 per share, with a total value of $59,454.00. On Tuesday, September 27th, Phillip Md Et Al Frost purchased 1,800 shares of Opko Health stock. The stock was acquired at an average price of $11.16 per share, with a total value of $20,088.00. On Monday, September 26th, Phillip Md Et Al Frost purchased 1,800 shares of Opko Health stock. The stock was acquired at an average price of $11.04 per share, with a total value of $19,872.00. On Friday, September 23rd, Phillip Md Et Al Frost purchased 1,800 shares of Opko Health stock. The stock was acquired at an average price of $10.95 per share, with a total value of $19,710.00.

Opko Health Inc. (NYSE:OPK) opened at 9.45 on Monday. The stock has a 50 day moving average of $10.08 and a 200-day moving average of $10.07. Opko Health Inc. has a 12 month low of $7.12 and a 12 month high of $11.85. The stock has a market cap of $5.20 billion and a P/E ratio of 39.54.

Opko Health (NYSE:OPK) last announced its earnings results on Monday, August 8th. The company reported $0.02 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.05. The company had revenue of $357.10 million for the quarter, compared to analysts’ expectations of $324.11 million. The company’s quarterly revenue was up 742.2% compared to the same quarter last year. During the same period last year, the business earned ($0.09) EPS. On average, equities analysts forecast that Opko Health Inc. will post ($0.05) EPS for the current fiscal year.

Several research firms have recently commented on OPK. Jefferies Group restated a “hold” rating on shares of Opko Health in a report on Wednesday, August 17th. Oppenheimer Holdings Inc. restated an “outperform” rating on shares of Opko Health in a report on Saturday, June 25th. Standpoint Research boosted their price target on shares of Opko Health from $16.00 to $18.00 and gave the company a “buy” rating in a report on Tuesday, June 21st. Zacks Investment Research upgraded shares of Opko Health from a “sell” rating to a “hold” rating in a report on Tuesday, July 12th. Finally, JPMorgan Chase & Co. set a $14.00 price target on shares of Opko Health and gave the company a “buy” rating in a report on Tuesday, August 9th. Five equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $13.20.

A number of hedge funds and other institutional investors have recently made changes to their positions in OPK. California State Teachers Retirement System raised its position in shares of Opko Health by 6.1% in the second quarter. California State Teachers Retirement System now owns 682,157 shares of the company’s stock valued at $6,371,000 after buying an additional 39,160 shares during the period. Teachers Advisors Inc. raised its position in shares of Opko Health by 3.6% in the first quarter. Teachers Advisors Inc. now owns 325,172 shares of the company’s stock valued at $3,379,000 after buying an additional 11,403 shares during the period. Bank of New York Mellon Corp raised its position in shares of Opko Health by 3.7% in the second quarter. Bank of New York Mellon Corp now owns 1,343,344 shares of the company’s stock valued at $12,547,000 after buying an additional 47,942 shares during the period. BlackRock Group LTD raised its position in shares of Opko Health by 19.1% in the first quarter. BlackRock Group LTD now owns 251,817 shares of the company’s stock valued at $2,616,000 after buying an additional 40,321 shares during the period. Finally, Jaffetilchin Investment Partners LLC raised its position in shares of Opko Health by 1.2% in the second quarter. Jaffetilchin Investment Partners LLC now owns 450,450 shares of the company’s stock valued at $4,207,000 after buying an additional 5,182 shares during the period.

About Opko Health

Related posts

Leave a Comment